Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Evithrom Market Value Expansion And Long-Term Growth Outlook
Growth during the historic period was driven by elevated risks of surgical blood loss, a demand for rapid hemostatic action, the early adoption of thrombin-based products, a rising number of trauma incidents, and increased utilization in orthopedic surgeries.
The expansion observed during the forecast period is driven by an increase in surgical procedures, higher incidence of accidents and trauma cases, improvements in hospital facilities, advancements in thrombin formulations, and a stronger emphasis on surgical safety. Key developments shaping this period encompass the growing utilization of topical hemostatic agents, heightened demand within cardiovascular operations, broader application in trauma and emergency medical services, a preference for solutions enabling fast coagulation, and a greater acceptance of human-derived thrombin products.
Download A Free Sample Report For Comprehensive Market Insights:
Evithrom Market Growth Momentum: Which Factors Are Influencing Demand?
The expanding volume of surgical interventions is set to advance the evithrom market in the coming period. These interventions are defined as medical procedures involving physical changes or handling of internal tissues and organs. Their increase is fueled by progress in medical technology, which enhances both safety and efficiency during operations, alongside the growing incidence of chronic diseases necessitating more frequent surgeries. Evithrom aids in managing bleeding during such procedures by fostering clot development and improving hemostasis, especially in high-risk scenarios like cardiovascular or orthopedic operations. As an example, data from the International Society of Aesthetic Plastic Surgery in June 2024, a US nonprofit, showed that liposuction led surgical volumes in 2023 with over 2.2 million instances, while facial and cranial procedures surged by 19.6% to exceed 6.5 million. Consequently, this surge in surgical activity propels the evithrom market onward.
Evithrom Market Segment Outlook: Which Categories Are Expanding The Fastest?
The evithrom market covered in this report is segmented –
1) By Indication: Surgical Hemostasis, Trauma Care
2) By Formulation: Bovine Thrombin, Human Thrombin, Recombinant Thrombin
3) By Distribution Channel: Hospitals, Clinics And Diagnostic Centers, Online Pharmacies
Evithrom Market Key Companies And Competitive Benchmarking
Major companies operating in the evithrom market are Johnson & Johnson Inc.
Access The Complete Evithrom Market Report:
Evithrom Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the evithrom market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evithrom market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model